Należności Handlowe Zmiana Data
Amarin USD 126.83M 477K 2025-12
Ardelyx USD 82.84M 10.99M 2026-03
Baxter International USD 1.86B 158M 2026-06
Bayer EUR 18.7B 146M 2026-06
BioCryst Pharmaceuticals USD 110.76M 3.94M 2026-06
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Gilead Sciences USD 5.06B 314M 2026-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
Halozyme Therapeutics USD 453.33M 4.66M 2026-06
Insmed USD 215.32M 36.77M 2026-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
J&J USD 22.54B 1.21B 2026-03
Lexicon Pharmaceuticals USD 2.38M 50K 2025-12
Moderna USD 17M 54M 2026-06
Omeros USD 8.08M 440K 2024-06
Pfizer USD 16.19B 19M 2026-06
PTC Therapeutics USD 219.92M 38.3M 2026-03
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Sangamo BioSciences USD 581K 110K 2024-06
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
Teva Pharmaceutical Industries USD 3.49B 100M 2026-06
United Therapeutics USD 310.3M 1.7M 2026-06
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06